Primero Mining : Lifshitz & Miller Law Firm : Announces Investigation of Cigna Corporation, CTI Biopharma Corp., G. Willi-Food International Ltd., MannKind Corporation, Navient Corporation, Primero Mining Corp., and Skullcandy, Inc.

NEW YORK, Feb. 23, 2016 /PRNewswire/ --

Cigna Corporation (CI)

Lifshitz & Miller announces investigation on behalf of investors of Cigna. Specifically, the investigation relates to whether Cigna's appeals and grievances procedures were in compliance with federal standards; and Cigna's noncompliance with federal standards posed a serious threat to the health and safety of Medicare beneficiaries.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at [phone] or e-mail at [e-mail].

CTI Biopharma Corp. (CTIC)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the CTIC board. The investigation relates to whether (i) pacritinib was a potential cause in the death and injuries of several patients; (ii) CTIC's clinical trials showed the dangers of pacritinib usage; and (iii) CTIC's new drug application would likely be withdrawn.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at [phone] or e-mail at [e-mail].

G. Willi-Food International Ltd. (WILC)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the WILC board. On February 17, 2016, the Israel Securities Authority ("ISA") conducted a search at the Company's offices, and the offices of its Parent Company during which certain computers and other materials were seized by the ISA.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at [phone] or e-mail at [e-mail].

MannKind Corporation (MNKD)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the MNKD board. Specifically, Bloomberg quoted Sanofi's spokesman saying that Sanofi terminated the agreement due to low level of Afrezza prescriptions. StreetInsider reported that Sanofi's spokesman said that Afrezza prescription levels never even met "modest expectations."

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at [phone] or e-mail at [e-mail].

Navient Corporation (NAVI)

Lifshitz & Miller announces investigation on behalf of investors of NAVI. Specifically, the investigation relates to whether Navient's loan servicing practices were in compliance with federal regulation.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at [phone] or e-mail at [e-mail].

Primero Mining Corp. (PPP)

Lifshitz & Miller announces investigation into possible breaches of fiduciary duties by the PPP board. Specifically, the investigation relates to whether PPP's Mexican subsidiary was inappropriately recording revenues and taxes from sales under its silver purchase agreement between PPP and Silver Wheaton.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at [phone] or e-mail at [e-mail].

Skullcandy, Inc. (SKUL)

Lifshitz & Miller announces investigation on behalf of investors of SKUL. On January 11, 2016, SKUL updated the Company's financial outlook for the fourth quarter 2015 and announced that the Company had missed its quarterly net sales projections.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at [phone] or e-mail at [e-mail].

ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller. The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: [phone]. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone: [phone]
Facsimile: 516-280-7376
Email: [e-mail]

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-cigna-corporation-cti-biopharma-corp-g-willi-food-international-ltd-mannkind-corporation-navient-corporation-primero-mining-corp-and-skullcandy-inc-300225016.html

SOURCE Lifshitz & Miller Law Firm